Leonard Mazur
2021
In 2021, Leonard Mazur earned a total compensation of $787.9K as Executive Chairman at Citius Pharmaceuticals, a 43% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $245,000 |
|---|---|
| Option Awards | $194,978 |
| Salary | $347,917 |
| Total | $787,895 |
Mazur received $347.9K in salary, accounting for 44% of the total pay in 2021.
Mazur also received $245K in non-equity incentive plan and $195K in option awards.
Rankings
In 2021, Leonard Mazur's compensation ranked 9,526th out of 12,415 executives tracked by ExecPay. In other words, Mazur earned more than 23.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,526 out of 12,415 | 23rd |
Division Manufacturing | 4,223 out of 5,508 | 23rd |
Major group Chemicals And Allied Products | 1,872 out of 2,378 | 21st |
Industry group Drugs | 1,661 out of 2,099 | 21st |
Industry Pharmaceutical Preparations | 1,237 out of 1,549 | 20th |
Source: SEC filing on December 20, 2021.
Mazur's colleagues
We found three more compensation records of executives who worked with Leonard Mazur at Citius Pharmaceuticals in 2021.
News
Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
January 26, 2024
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018